What it's for (Indications)
- Alverine citrate and simethicone is a fixed-dose combination medication primarily indicated for the symptomatic relief of functional gastrointestinal disorders.
- This includes conditions such as Irritable Bowel Syndrome (IBS), spastic colon, and other functional bowel disturbances characterized by abdominal pain, discomfort, bloating, and excessive gas.
- Alverine citrate acts as a musculotropic antispasmodic, directly targeting smooth muscle spasms in the gut to alleviate pain.
- Simethicone, an antiflatulent, reduces surface tension of gas bubbles, facilitating their expulsion and thereby relieving bloating and gaseous distension.
- The combination is particularly beneficial for patients experiencing both spasmodic pain and prominent flatulence, aiming to improve overall gastrointestinal comfort and quality of life.
- Its use should be guided by a definitive diagnosis of a functional gastrointestinal disorder, after exclusion of serious underlying pathologies.
Dosage Information
| Type | Guideline |
|---|---|
| Standard | The recommended dosage for alverine citrate and simethicone typically involves oral administration of one capsule, usually taken one to three times daily. It is generally advised to take the medication before meals to optimize its therapeutic effects on post-prandial symptoms. The precise dosage and duration of treatment should always be determined by a healthcare professional, based on the individual patient's condition, symptom severity, and response to therapy. Patients should adhere strictly to the prescribed dose and not exceed the maximum recommended daily intake without medical consultation. It is imperative to consult the specific product's patient information leaflet or a physician for tailored dosage instructions, as formulations and local guidelines may vary. Self-adjustment of dosage is not recommended. |
Safety & Warnings
Common Side Effects
- While generally well-tolerated, alverine citrate and simethicone can be associated with various side effects, most of which are mild and transient.
- Common side effects reported with the alverine component include headache, dizziness, nausea, and dry mouth.
- Hypersensitivity reactions are possible, manifesting as skin rash, pruritus, urticaria, angioedema, or, rarely, more severe anaphylactic reactions.
- There have been isolated post-marketing reports of hepatobiliary reactions, including elevations in liver enzymes, though a causal link is not firmly established and these are considered rare.
- Simethicone is largely inert and not absorbed systemically, thus its side effects are minimal; rarely, mild gastrointestinal disturbances such as constipation or diarrhea have been reported.
- Patients experiencing persistent or severe side effects, or any signs of an allergic reaction or liver dysfunction, should seek immediate medical attention and discontinue the medication.
Serious Warnings
- Black Box Warning: This medication, alverine citrate and simethicone, does not currently carry a formal Black Box Warning from regulatory authorities such as the U.S. Food and Drug Administration (FDA). However, healthcare professionals and patients should be acutely aware of several serious warnings associated with its use, which necessitate careful consideration. **Serious Warnings**: 1. **Risk of Masking Serious Conditions**: The symptomatic relief provided by alverine citrate and simethicone, particularly the alleviation of abdominal pain and discomfort, can potentially mask the signs and symptoms of more severe underlying gastrointestinal pathologies. These include, but are not limited to, intestinal obstruction, appendicitis, inflammatory bowel disease flares, or other acute surgical abdominal conditions. It is paramount that a comprehensive diagnostic evaluation is performed to rule out such serious disorders before initiating treatment, especially in patients with new-onset or atypical gastrointestinal symptoms, unexplained weight loss, or signs of gastrointestinal bleeding. 2. **Hypersensitivity Reactions**: Although rare, severe hypersensitivity reactions, including anaphylaxis, angioedema, and widespread urticaria, have been reported following the administration of alverine citrate. Patients should be advised to discontinue the medication immediately and seek urgent medical attention if they experience any signs of an allergic reaction, such as swelling of the face, lips, tongue, or throat, difficulty breathing, or severe rash. 3. **Potential for Hepatic Dysfunction**: While infrequent, there have been isolated post-marketing reports of transient elevations in liver enzymes associated with alverine citrate use. Although a definitive causal relationship is not always established, patients with pre-existing hepatic impairment should be monitored with caution, and the medication should be used with discretion in such individuals. Persistent or clinically significant elevations in liver enzymes warrant discontinuation and further investigation.
- Patients should be advised that alverine citrate and simethicone may mask symptoms of more serious underlying gastrointestinal conditions, such as intestinal obstruction, appendicitis, or other acute abdominal pathologies.
- Therefore, a thorough diagnostic evaluation is crucial before initiating treatment, especially in cases of new onset or worsening symptoms, unexplained weight loss, or gastrointestinal bleeding.
- Hypersensitivity reactions, including anaphylaxis, can occur, and patients should be counselled to discontinue the medication and seek immediate medical attention if signs of a severe allergic reaction develop.
- Although rare, liver enzyme elevations have been reported with alverine citrate; caution is advised in patients with pre-existing liver impairment, and monitoring may be considered in prolonged therapy.
- The safety and efficacy in pediatric populations have not been extensively established, and its use in children should only be under strict medical supervision.
- Due to limited data, use during pregnancy and lactation should be undertaken only if clearly necessary and after a comprehensive risk-benefit assessment by a healthcare professional.
- Driving or operating machinery should be avoided if dizziness or drowsiness occurs.
How it Works (Mechanism of Action)
The therapeutic efficacy of alverine citrate and simethicone stems from the synergistic action of its two active components. Alverine citrate functions as a musculotropic antispasmodic agent, exerting a direct relaxant effect on the smooth muscle of the gastrointestinal tract. Its precise mechanism of action is thought to involve several pathways, including antagonism of calcium channels, which leads to a reduction in calcium influx into smooth muscle cells, thereby inhibiting muscle contraction and spasm. This direct action alleviates abdominal pain and discomfort associated with conditions like Irritable Bowel Syndrome without producing significant anticholinergic side effects. Simethicone, on the other hand, is an antiflatulent that works by reducing the surface tension of gas bubbles present in the gastrointestinal lumen. This physical action causes the smaller, tenacious gas bubbles, which contribute to bloating and distension, to coalesce into larger, more easily passable bubbles, facilitating their expulsion through belching or flatulence. Simethicone is pharmacologically inert and not absorbed systemically, acting purely within the gut. Together, these agents address both the spasmodic pain and gaseous symptoms characteristic of functional bowel disorders.
Commercial Brands (Alternatives)
No other brands found for this formula.